Gilead Sciences, Inc. v. Natco Pharma Limited

Petition for certiorari denied on March 9, 2015

Docket No.	Op. Below	Argument	Opinion	Vote	Author	Term
14-647	Fed. Cir.	N/A	N/A	N/A	N/A	OT 2014

Issue: Whether, contrary to this Court"s consistent and longstanding precedent and Congress"s intent, the double-patenting doctrine can be used to invalidate a properly issued patent before its statutory term has expired using a second, later-issuing patent whose term of exclusivity is entirely subsumed within that first patent"s term.

Date	Proceedings and Orders (key to color coding)
10/09/2014	Application (14A391) to extend the time to file a petition for a writ of certiorari from October 27, 2014 to November 26, 2014, submitted to The Chief Justice.
10/15/2014	Application (14A391) granted by The Chief Justice extending the time to file until November 26, 2014.
11/26/2014	Petition for a writ of certiorari filed. (Response due January 5, 2015)
12/22/2014	Order extending time to file response to petition to and including February 4, 2015.
12/29/2014	Brief amici curiae of The Pharmaceutical Research and Manufacturers of America, et al, filed.
02/04/2015	Brief of respondents Natco Pharma Limited, et al. in opposition filed.
02/17/2015	Reply of petitioners Gilead Sciences, Inc., et al. filed.
02/18/2015	DISTRIBUTED for Conference of March 6, 2015.
03/09/2015	Petition DENIED.